Chapter 1. Parenteral Small Joint Osteoarthritis Therapeutics Market – Scope & Methodology
1.1    Market Segmentation
1.2    Scope, Assumptions & Limitations
1.3    Research Methodology
1.4    Primary Sources
1.5    Secondary Sources
 
Chapter 2. Parenteral Small Joint Osteoarthritis Therapeutics Market– Executive Summary
2.1    Market Size & Forecast – (2022 – 2030) ($M/$Bn)
2.2    Key Trends & Insights
          2.2.1    Demand Side
          2.2.2    Supply Side
2.3    Attractive Investment Propositions
2.4    COVID-19 Impact Analysis
 
Chapter 3. Parenteral Small Joint Osteoarthritis Therapeutics Market – Competition Scenario
3.1    Market Share Analysis & Company Benchmarking
3.2    Competitive Strategy & Development Scenario
3.3    Competitive Pricing Analysis
3.4    Supplier-Distributor Analysis
 
Chapter 4. Parenteral Small Joint Osteoarthritis Therapeutics Market Entry Scenario
4.1    Regulatory Scenario
4.2    Case Studies – Key Start-ups
4.3    Customer Analysis
4.4    PESTLE Analysis
4.5    Porters Five Force Model
          4.5.1    Bargaining Power of Suppliers
          4.5.2    Bargaining Powers of Customers
          4.5.3    Threat of New Entrants
          4.5.4    Rivalry among Existing Players
          4.5.5    Threat of Substitutes
 
Chapter 5. Parenteral Small Joint Osteoarthritis Therapeutics Market – Landscape
5.1    Value Chain Analysis – Key Stakeholders Impact Analysis
5.2    Market Drivers
5.3    Market Restraints/Challenges
5.4    Market Opportunities
 
Chapter 6. Parenteral Small Joint Osteoarthritis Therapeutics Market – By Drugs
6.1    Introduction/Key Findings   
6.2    Non-steroidal Anti-inflammatory Drugs (NSAIDs)
          6.2.1    Naproxen
          6.2.2    Aspirin
          6.2.3    Diclofenac
          6.2.4    Ibuprofen
6.3    Visco supplementation agents
6.4    Corticosteroids 
6.5    Others
6.6    
6.7    Y-O-Y Growth trend Analysis By Drugs
6.8    Absolute $ Opportunity Analysis By Drugs, 2023-2030
 
Chapter 7. Parenteral Small Joint Osteoarthritis Therapeutics Market – By Purchasing Pattern
7.1    Introduction/Key Findings   
7.2    Prescription Drugs 
7.3    Over-the-counter Drugs
7.4    Y-O-Y Growth  trend Analysis By Purchasing Pattern
7.5    Absolute $ Opportunity Analysis By Purchasing Pattern, 2023-2030
 
Chapter 8. Parenteral Small Joint Osteoarthritis Therapeutics Market – By Distribution Channel
8.1    Introduction/Key Findings   
8.2    Hospital Pharmacies
8.3    Hypermarket & Supermarket
8.4    Online Pharmacies
8.5    Retail Pharmacies
8.6    Others
8.7    Y-O-Y Growth trend Analysis Distribution Channel
8.8    Absolute $ Opportunity Analysis Distribution Channel, 2023-2030
 
Chapter 9. Parenteral Small Joint Osteoarthritis Therapeutics Market, By Geography – Market Size, Forecast, Trends & Insights
9.1    North America
          9.1.1    By Country
                    9.1.1.1    U.S.A.
                    9.1.1.2    Canada
                    9.1.1.3    Mexico
          9.1.2    By Drugs
                    9.1.2.1    By Purchasing Pattern
          9.1.3    By Distribution Channel
          9.1.4    Countries & Segments - Market Attractiveness Analysis
9.2    Europe
          9.2.1    By Country
                    9.2.1.1    U.K
                    9.2.1.2    Germany
                    9.2.1.3    France
                    9.2.1.4    Italy
                    9.2.1.5    Spain
                    9.2.1.6    Rest of Europe
          9.2.2    By Drugs
          9.2.3    By Purchasing Pattern
          9.2.4    By Distribution Channel
          9.2.5    Countries & Segments - Market Attractiveness Analysis
9.3    Asia Pacific
          9.3.1    By Country
                    9.3.1.1    China
                    9.3.1.2    Japan
                    9.3.1.3    South Korea
                    9.3.1.4    India      
                    9.3.1.5    Australia & New Zealand
                    9.3.1.6    Rest of Asia-Pacific
          9.3.2    By Drugs
          9.3.3    By Purchasing Pattern
          9.3.4    By Distribution Channel
          9.3.5    Countries & Segments - Market Attractiveness Analysis
9.4    South America
          9.4.1    By Country
                    9.4.1.1    Brazil
                   9.4.1.2    Argentina
                    9.4.1.3    Colombia
                    9.4.1.4    Chile
                    9.4.1.5    Rest of South America
          9.4.2    By Drugs
          9.4.3    By Purchasing Pattern
          9.4.4    By Distribution Channel
          9.4.5    Countries & Segments - Market Attractiveness Analysis
9.5    Middle East & Africa
          9.5.1    By Country
                    9.5.1.1    United Arab Emirates (UAE)
                    9.5.1.2    Saudi Arabia
                    9.5.1.3    Qatar
                    9.5.1.4    Israel
                    9.5.1.5    South Africa
                    9.5.1.6    Nigeria
                    9.5.1.7    Kenya
                    9.5.1.8    Egypt
                    9.5.1.9    Rest of MEA
          9.5.2    By Drugs
          9.5.3    By Purchasing Pattern
          9.5.4    By Distribution Channel
          9.5.5    Countries & Segments - Market Attractiveness Analysis
 
Chapter 10. Parenteral Small Joint Osteoarthritis Therapeutics Market – Company Profiles – (Overview, Product Portfolio, Financials, Strategies & Developments)
10.1    Abbott Laboratories
10.2    ABIOGEN PHARMA S.p.A
10.3    Ampio Pharmaceuticals Inc.
10.4    Anika Therapeutics Inc.
10.5    Bayer Aktiengesellschaft
10.6    Bioventus
10.7    Eli Lilly and Company.
10.8    Ferring B.V.
10.9    Flexion Therapeutics, Inc.
10.10    GlaxoSmithKline Plc. 
10.11    Horizon Therapeutics plc.
10.12    Johnson & Johnson Inc.
10.13    Medivir
10.14    Merck Sharp & Dohme Corp.
10.15    Roche